Skip to main content
Premium Trial:

Request an Annual Quote

Dog Droppings Database

The Tel Aviv city council has approved the development of a DNA database of dogs living in the city to crack down on owners who do not clean up after their pets, the Times of Israel reports.

The paper adds that dog owners will be required to submit genetic samples from their dogs when they receive or renew their dogs' licenses. The Times of Israel adds that Tel Aviv previously increased the fines for leaving dog waste on city streets but says that did not deter violators. Under this new program, unpicked-up dog dropping will undergo DNA testing and fines sent to the offenders, it adds.

Tel Aviv is not the first region to adopt such a measure. In April, the Leitrim County Council in Ireland adopted a similar dog waste DNA testing program and in 2018, Breckinridge, Colorado, announced it would be using DNA testing to identify dogs whose owners did not pick up after them. A condo board in Baltimore and an apartment complex on Long Island have also taken such an approach to tackle unscooped poop.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.